[New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)].
Fölsch
U R
UR
Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstraße 12, 24105 Kiel, Deutschland. urfoelsch@1med.uni-kiel.de
Nitschmann
S
S
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine